Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2024

Mar 12, 2024

30786_dirs_2024-03-12_110da6ca-5d97-4b3c-b3d8-734b8eee8be7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-03-08

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-08 Non-Qualified Stock Option (right to buy) $343.76 A 14137 Acquired 2034-03-08 Bio-Rad A Common Stock (14137) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 432920 Direct
Bio-Rad B Common Stock 361409 Direct
Bio-Rad B Common Stock 12949 Indirect
Bio-Rad B Common Stock 4060054 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.